Cabeza Montilla, Laura Author
Nano-engineering of 5-fluorouracil-loaded magnetoliposomes for combined hyperthermia and chemotherapy against colon cancer
- Clares B.
- Biedma-Ortiz R.
- Sáez-Fernández E.
- Prados J.
- Melguizo C.
- Cabeza L.
- Ortiz R.
- Arias J.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS - 1/1/2013
- SJR Quartile: Q1
- JCR Impact Factor: 4.245 (2013)
- CiteScore: 9 (2020)
- SJR: 1.566 (2013
- SNIP: 1.721 (2013
- JCR 5-year Impact Factor: 4.737
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Colon cancer therapy: Recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs
- Prados J.
- Melguizo C.
- Ortiz R.
- Perazzoli G.
- Cabeza L.
- Álvarez P.
- Rodriguez-Serrano F.
- Aranega A.
Anti-Cancer Agents in Medicinal Chemistry - 29/11/2013
- SJR Quartile: Q1
- JCR Impact Factor: 2.939 (2013)
- CiteScore: 3.5 (2020)
- SJR: 1.122 (2013
- SNIP: 0.836 (2013
- JCR 5-year Impact Factor: 3.37
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)
- Scopus
- ORCID
- Web of Science
Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
- Prados, Jose
- Melguizo, Consolacion
- Perazzoli, Gloria
- Cabeza, Laura
- Carrasco, Esther
- Oliver, Jaime
- Jimenez-Luna, Cristina
- Leiva, Maria C.
- Ortiz, Raul
- Alvarez, Pablo J.
- Aranega, Antonia
Recent patents on anti-cancer drug discovery - 1/01/2014
- SJR Quartile: Q1
- JCR Impact Factor: 4.295 (2014)
- CiteScore: 5.1 (2020)
- SJR: 1.092 (2014
- SNIP: 0.837 (2014
- JCR 5-year Impact Factor: 2.909
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2)
- Scopus
- ORCID
- Web of Science
Polystyrene nanoparticles facilitate the internalization of impermeable biomolecules in non-tumour and tumour cells from colon epithelium
- Cabeza L.
- Cano-Cortés V.
- Rodríguez M.
- Vélez C.
- Melguizo C.
- Sánchez-Martín R.
- Prados J.
JOURNAL OF NANOPARTICLE RESEARCH - 1/1/2015
- JCR Quartile: Q2 (2015)
- SJR Quartile: Q2
- JCR Impact Factor: 2.101 (2022)
- Category normalized Impact: 1.466 (2015)
- CiteScore: 3.4 (2020)
- SJR: 0.568 (2015
- SNIP: 0.734 (2015
- JCR 5-year Impact Factor: 2.499
- JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
- SJR Categories: Atomic and Molecular Physics, and Optics (Q2); Bioengineering (Q2); Chemistry (miscellaneous) (Q2); Condensed Matter Physics (Q2); Materials Science (miscellaneous) (Q2); Modeling and Simulation (Q2); Nanoscience and Nanotechnology (Q2)
Temozolomide resistance in glioblastoma cell lines: Implication of MGMT, MMR, P-glycoprotein and CD133 expression
- Perazzoli G.
- Prados J.
- Ortiz R.
- Caba O.
- Cabeza L.
- Berdasco M.
- Gónzalez B.
- Melguizo C.
PLoS ONE - 8/10/2015
- SJR Quartile: Q1
- JCR Impact Factor: 3.057 (null)
- CiteScore: 2.97 (2018)
- SJR: 1.427 (2015
- SNIP: 1.149 (2015
- JCR 5-year Impact Factor: 3.535
- JCR Categories: MULTIDISCIPLINARY SCIENCES
- SJR Categories: Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(Butylcyanoacrylate) nanoparticles
Drug Design Development and Therapy - 14/12/2015
- SJR Quartile: Q1
- JCR Impact Factor: 2.881 (2015)
- CiteScore: 3.27 (2018)
- SJR: 0.982 (2015
- SNIP: 0.978 (2015
- JCR 5-year Impact Factor: 2.962
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)
- Scopus
- ORCID
- Web of Science
Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(Butylcyanoacrylate) nanoparticles
- Cabeza L.
- Ortiz R.
- Arias J.
- Prados J.
- Martínez M.
- Entrena J.
- Luque R.
- Melguizo C.
International Journal of Nanomedicine - 13/2/2015
- SJR Quartile: Q1
- JCR Impact Factor: 4.32 (2015)
- CiteScore: 9.2 (2020)
- SJR: 1.323 (2015
- SNIP: 1.366 (2015
- JCR 5-year Impact Factor: 5.034
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Organic Chemistry (Q1)
- Scopus
- ORCID
- Web of Science
Poly(butylcyanoacrylate) and Poly(?-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer
- Ortiz R.
- Cabeza L.
- Arias J.
- Melguizo C.
- Álvarez P.
- Vélez C.
- Clares B.
- Áranega A.
- Prados J.
AAPS Journal - 24/7/2015
- SJR Quartile: Q1
- JCR Impact Factor: 3.819 (2015)
- CiteScore: 6.8 (2020)
- SJR: 1.295 (2015
- SNIP: 1.421 (2015
- JCR 5-year Impact Factor: 4.618
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Nanopartículas Magnéticas en el Diagnóstico y Tratamiento del Cáncer
- Kevin Doello
- Laura Cabeza
- Raul Ortiz
- José Luis Arias Mediano
- Consolación Melguizo
- José Carlos Prados
Actualidad médica - 2015
- Dialnet
73P Generation of miR-21 sponges in lung cancer treatment
- Rama A.
- Hernández R.
- Jiménez J.
- Leiva M.
- Jiménez-Luna C.
- Cabeza L.
- Perazzoli G.
- Prados J.
Journal of Thoracic Oncology - 1/4/2016
- SJR Quartile: Q1
- JCR Impact Factor: 6.595 (2016)
- CiteScore: 20 (2020)
- SJR: 2.754 (2016
- SNIP: 1.756 (2016
- JCR 5-year Impact Factor: 5.983
- JCR Categories: RESPIRATORY SYSTEM
- SJR Categories: Medicine (miscellaneous) (Q1); Oncology (Q1); Pulmonary and Respiratory Medicine (Q1)
Mejora de la actividad antitumoral de agentes citotóxicos mediante el uso de nanoplataformas poliméricas: aplicación en cáncer de colon, mama y pulmón
- Laura Cabeza
- Consolación Melguizo
- José Carlos Prados Salazar
- Raul Ortiz Quesada
2017
- Dialnet
Combinaciones terapéuticas y sus ventajas en el tratamiento del síndrome de dolor miofascial
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Acercamiento multidisciplinar a la salud: Volumen IV - 2019
- Dialnet
Efectos del trabajo a turnos en enfermeras del servicio de urgencias hospitalarias entre 55 y 65 años en las etapas menopausia y post-menopausia
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Investigación en salud y envejecimiento: Volumen VI - 2019
- Dialnet
This author has no conferences.
This author has no patents.
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- JCR Impact Factor: 4.9 (2023)
- JCR 5-year Impact Factor: 5.5
- JCR Categories: PHARMACOLOGY & PHARMACY
- Scopus
- ORCID
- Web of Science
h index
Scopus: 14
Web of Science: 21
i10 index
Scopus: 19
Web of Science: 30
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador